|Articles|April 20, 2023
Mass Spectra of Designer Drugs 2023
With a continued need for comprehensive forensic data to keep up with the rapid pace of designer drug synthesis, John Wiley & Sons have made a new mass spectral database designed for laboratory use.
With a continued need for comprehensive forensic data to keep up with the rapid pace of designer drug synthesis, John Wiley & Sons have made a new mass spectral database designed for laboratory use. According to the company, this release features over 34,000 mass spectra of more than 26,000 unique chemical compounds with detailed information and chemical structures for each entry.
John Wiley & Sons, Inc.
Hoboken, New Jersey, USA
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
Navigating Adverse Reactions in GLP-1 Treatment
2
Decoding Sweet Potato Drought Resilience: Metabolomic Evidence from UPLC-MS Profiling
3
Toward Safer Diabetes Devices: GC–MS Detection of Allergens in Sensors, Pumps, and Infusion Sets
4
Advancing RNA-Based Therapeutics: IQ Consortium Experts on Optimizing Chromatographic Bioanalysis
5
